Butkiewicz, Dorota <br/><br/>
The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.  [electronic resource] 

 -  International journal of cancer  Nov 2015 
 - 2332-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.29605  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cyclooxygenase 2--genetics<br/>Female<br/>Humans<br/>Lung Neoplasms--genetics<br/>Male<br/>Matrix Metalloproteinase 2--genetics<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Survival Analysis<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor Receptor-2--genetics<br/>White People--genetics